Jinkyu Park1, Muhammad Riaz2, Lingfeng Qin3

  • 1Yale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine Yale School of Medicine, New Haven, CT 06511, USA; Yale Stem Cell Center, New Haven, CT 06520, USA; Department of Physiology, College of Medicine, Hallym University, Hallymdaehak-gil, Chuncheon-si 24252, Gangwon-Do, South Korea.

Cell stem cell
|December 7, 2024
PubMed
概括

使用干细胞的工程血管移植显示出对先天性心脏缺陷的前景. 这些新植入物可以防止凝血并很好地结合,为患者提供潜在的新疗法.